122
122
Sep 28, 2011
09/11
by
CSPAN2
tv
eye 122
favorite 0
quote 0
mr. shimkus or mr. guthrie asked you if you said you're going to get back to them, but i would really like to get some answers, you know, obviously you are not prepared or do not feel you have an answer today, but i'd like you to get back to us through the chairman if you could. >> we'd be happy to, congressman. i mention we have an upcoming report that will give further analysis and further economic analysis is also intensely underway. >> with that relate to this or you don't know for sure? >> hopefully will get a better understanding of the causes. >> mr. chairman, if he could get back to us on that because i know many of us have asked the same question and would really like to know. >> if the chairman would yield just on this point. and i thank my friend for following up on this debate in this question. but in my opening statement they didn't just focus on the government pricing. i did say insurers, too. so we are all in this together in the market going to work if that were. i just want to correct t
mr. shimkus or mr. guthrie asked you if you said you're going to get back to them, but i would really like to get some answers, you know, obviously you are not prepared or do not feel you have an answer today, but i'd like you to get back to us through the chairman if you could. >> we'd be happy to, congressman. i mention we have an upcoming report that will give further analysis and further economic analysis is also intensely underway. >> with that relate to this or you don't know...
110
110
Sep 22, 2011
09/11
by
CSPAN
tv
eye 110
favorite 0
quote 0
mr. shimkus: thank you, mr. speaker. and i do apologize for my friend from california for coming late and kind of disrupting, you know, what was planned to be a closing. but this is an important debate and my colleague from california and i have crossed sabres many times on these issues. and i don't question his commitment to the environment and the regs and rules and the like, but as he knows, i'm from southern illinois. i'm from an area that was devastated in the jobs issue and during the 1992 clean air act. and i'm from an area of the country that still is not being all it can be based upon the excessive rules and regulations that come out of washington, d.c. so the train act is really a first start to help us ask a simple question. shouldn't we as an interagency process, shouldn't we at least ask the basic question of what is this going to do on the effect on jobs? and what is it going to do on the effect of our competitiveness worldwide? so it's really a basic debate. it's a good one to have. i applaud the chairman
mr. shimkus: thank you, mr. speaker. and i do apologize for my friend from california for coming late and kind of disrupting, you know, what was planned to be a closing. but this is an important debate and my colleague from california and i have crossed sabres many times on these issues. and i don't question his commitment to the environment and the regs and rules and the like, but as he knows, i'm from southern illinois. i'm from an area that was devastated in the jobs issue and during the...
102
102
Sep 24, 2011
09/11
by
CSPAN2
tv
eye 102
favorite 0
quote 0
mr. shimkus. it's been widely reported that information of the drug shortage in acted in a market tries to sell drugs in short supply to the pharmacist for hospitals. does this present a safety concern? >> yes it does, congressman. >> howell and what can you do about it? >> this is largely unregulated. the commission is involved in some degree but -- >> they don't have the expertise that you have. would you submit a proper answer informing me of what we have to do to address that particular problem? >> i would be happy to do that. >> do you know of these drugs have been stored properly to ensure the effectiveness, whether they have been delivered or whether they are free of self and contaminants or -- yes or no? >> unfortunately we know very little about the products in the market. >> as i mentioned the many factors to maintain the records establishing the drugs and its materials would produce and putting all the information relative to the producers, and the manufacturers, distributors and import
mr. shimkus. it's been widely reported that information of the drug shortage in acted in a market tries to sell drugs in short supply to the pharmacist for hospitals. does this present a safety concern? >> yes it does, congressman. >> howell and what can you do about it? >> this is largely unregulated. the commission is involved in some degree but -- >> they don't have the expertise that you have. would you submit a proper answer informing me of what we have to do to...
122
122
Sep 23, 2011
09/11
by
CSPAN
tv
eye 122
favorite 0
quote 0
mr. shimkus: thank you. thank you, mr. speaker. mr. speaker, this marks the first of what i hope to be many times to address you and my colleagues on an issue that i have been graced with having the responsibility to deal in the public policy arena about and that's the whole issue of nuclear waste. now, when people talk about nuclear waste in this debate about where it is and why it's there, they primarily talk about our nuclear utilities and especially after fukushima daiichi, people understand that when you store high level nuclear waste on sites and if there's a disaster that occurs and if the pools run dry then you might have a melting which might spread radio activity and that's not good for anybody. and that's a good debate to have because we have nuclear waste stored all over this country. but i'm not here really to talk about the private for-profit sector of the nuclear industry today, i'm here to tell another story. another story that really talks about why we have government and why there's still a need for some government en
mr. shimkus: thank you. thank you, mr. speaker. mr. speaker, this marks the first of what i hope to be many times to address you and my colleagues on an issue that i have been graced with having the responsibility to deal in the public policy arena about and that's the whole issue of nuclear waste. now, when people talk about nuclear waste in this debate about where it is and why it's there, they primarily talk about our nuclear utilities and especially after fukushima daiichi, people...
90
90
Sep 28, 2011
09/11
by
CSPAN2
tv
eye 90
favorite 0
quote 0
mr. shimkus.w, it's been widely reported that when information becomes public about a drug shortage, an active gray market tries to sell drugs in short supplies to pharmacists or hospitals. does this prevent a safety concern? >> yes, it does, congressman. >> why and how and what can you do about it? >> well,s this is largely unregulated. the federal trade commission is involved to some degree, but unfortunately -- >> they don't have the expertise that you have, and would you submit to us a proper answer informing me what we have to do to address that particular problem? >> be happy to do that. >> now, ed in the -- purchased in the gray market, do we know whether the drugs have been diluted or whether the drugs are free of filth and contaminants or adulterates, yes or no? >> no. unfortunately, we know very little about the products in the gray market. >> as i mentioned, i have a bill that would require manufacturers to maintain records establishing where the drug and its raw materials were produced
mr. shimkus.w, it's been widely reported that when information becomes public about a drug shortage, an active gray market tries to sell drugs in short supplies to pharmacists or hospitals. does this prevent a safety concern? >> yes, it does, congressman. >> why and how and what can you do about it? >> well,s this is largely unregulated. the federal trade commission is involved to some degree, but unfortunately -- >> they don't have the expertise that you have, and would...
108
108
Sep 24, 2011
09/11
by
CSPAN2
tv
eye 108
favorite 0
quote 0
mr. shimkus.t's been widely reported that information of the drug shortage in acted in a market tries to sell drugs in short supply to the pharmacist for hospitals. does this present a safety concern? >> yes it does, congressman. >> howell and what can you do about it? >> this is largely unregulated. the commission is involved in some degree but -- >> they don't have the expertise that you have. would you submit a proper answer informing me of what we have to do to address that particular problem? >> i would be happy to do that. >> do you know of these drugs have been stored properly to ensure the effectiveness, whether they have been delivered or whether they are free of self and contaminants or -- yes or no? >> unfortunately we know very little about the products in the market. >> as i mentioned the many factors to maintain the records establishing the drugs and its materials would produce and putting all the information relative to the producers, and the manufacturers, distributors and importer
mr. shimkus.t's been widely reported that information of the drug shortage in acted in a market tries to sell drugs in short supply to the pharmacist for hospitals. does this present a safety concern? >> yes it does, congressman. >> howell and what can you do about it? >> this is largely unregulated. the commission is involved in some degree but -- >> they don't have the expertise that you have. would you submit a proper answer informing me of what we have to do to...